Found 10 matching trials
OPT-CAD Score GUIded Dual ANtiplatelet De-esCalation Time NA Monotherapy with a P2Y12 inhibitor after a minimum period of DAPT following...
Show More Location
General Hospital of Northern Theater Command
Learn More & Join Trial
The Switching Antiplatelet-9 (SWAP-9) Study PHASE4 The purpose of this study is to compare the pharmacodynamic effects of ABCD...
Show More Location
University of Florida
Learn More & Join Trial
De-escalating Antiplatelet Therapy to Assess Platelet Reactivity and Outcomes in High Bleeding Risk Patients With Recent ACS PHASE3 High bleeding risk (HBR) patients, comprising up to 50% of those presenting...
Show More Location
Azienda Ospedaliera Universitaria Gaetano Martino
Learn More & Join Trial
Implementing Precision Medicine Approaches to Guide Anti-platelet Selection PHASE4 The study aims to determine the feasibility and clinical utility of incorpo...
Show More Location
LAC+USC Medical Center
Learn More & Join Trial
Genotype-Guided Abbreviated DAPT Versus Un-Guided De-escalation Therapy in Patients With ACS and HBR PHASE4 The aim of this study is to assess the safety and efficacy of the CYP2C19 g...
Show More Location
Samsung Medical Center
Learn More & Join Trial
Personalizing Thromboprophylaxis for Patients With Peripheral Artery Disease NA The goal of this clinical trial is to determine whether a personalised bloo...
Show More Location
Massachusetts General Hospital
Learn More & Join Trial
Assessment of an Early De-Escalation to a Low-potency Single Antiplatelet Therapy Guided by Genetics Versus a Systematic High-Potency Single Antiplatelet Therapy to Neutralize Bleeding Complications in Patients With High Bleeding Risk Beyond One Month After an Acute Coronary Syndrome PHASE3 Patients who suffered from acute coronary syndrome (ACS) are usually treate...
Show More Location
Hopital Pitié Salpetrière
Learn More & Join Trial
Safety and Efficacy of De-escalation Dual Antiplatelet Therapy After BioFreedom™ Stenting in ACS Patients With Moderate-to-high Ischemic and High Bleeding Risk NA Patients with acute coronary syndrome (ACS) who have both high ischemic ris...
Show More Location
General Hospital of Northern Theater Command
Learn More & Join Trial
Efficacy and Safety of Shortening Dual Antiplatelet Therapy Duration with IVUS Guidance in PCI Patients NA This study is designed to assess the efficacy and safety of de-escalating d...
Show More Location
University Medical Center of Ho Chi Minh City
Learn More & Join Trial
Tailoring Bleeding Reduction Approaches in Patients Undergoing PCI PHASE4 Two strategies have both proven to be effective in reducing bleeding compli...
Show More Location
University of Florida
Learn More & Join Trial